Nonthermal technique reduces bleeding and perforation risk
Standardizing a minimally invasive approach for Barrett’s Esophagus and Esophageal Cancer
Recent breakthroughs have brought attention to a previously overlooked condition
PSMA-targeted therapy for metastatic prostate cancer now offered at Cleveland Clinic Weston Hospital
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Nationally recognized urologic oncologist offers vision for growth, innovation, and excellence
Noninvasive modality gains ground in United States for patients with early-to-moderate disease
Cleveland Clinic Weston Hospital’s collaborative model elevates care for complex lung diseases
Interventional pulmonologists at Cleveland Clinic Indian River Hospital use robotic technology to reach small peripheral lung nodules
Trained in the use of multiple focal therapies for prostate cancer, Dr. Jamil Syed recommends HIFU for certain patients with intermediate-risk prostate cancer, especially individuals with small, well-defined tumors localized to the lateral and posterior regions of the gland.
Cleveland Clinic Weston Hospital is actively recruiting patients for an international, multicenter, phase III study comparing MIS versus open interval cytoreduction following neoadjuvant chemotherapy in patients with stage IIIC-IV epithelial ovarian cancer.
Advertisement
Advertisement